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Background
• Sex and gender have important 
influences on disease prevalence, 
pathophysiology, clinical 
presentation, treatment and 
prognosis. 
• It is essential to collect sex-
disaggregated data to understand 
susceptibility to disease and 
health outcomes. 
• Preliminary data from the 2020 
COVID-19 pandemic caused by the 
coronavirus SARS CoV-2 suggest 
that women with COVID-19 have 
significantly lower mortality rates 
compared to men globally.  
• The objective of this study is to 
evaluate sex differences in SARS-
CoV-2 infection rates and 
mortality at a country level 
Methods
• Data source: Global Health 5050 
website
o Housed University College London
o Collects government reported national 
surveillance data for COVID-19
o https://globalhealth5050.org/covid19
• These data lag behind figures for 
infections & deaths because only sex 
disaggregated data are collected
• Analysis of country data to determine 
the proportion of men and women with 
COVID-19 infection and associated 
deaths.
• Inclusion: Data from countries with 
completely sex disaggregated data
• Exclusion: Data from countries with 
incomplete sex disaggregation of data 
and from countries with no sex 
disaggregation of data
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Global Health 5050 data tracker 
https://globalhealth5050.org/covid19
accessed May 8, 2020
Snapshot of Global Health 5050 
database May 8, 2020
• 3,044,513 cases of COVID-
19 and 181,742 deaths in 
78 countries
• Sex disaggregated data
Complete 
disaggregation in 36 
countries
Partial disaggregation in 
26 countries
No disaggregation in 16 
countries
Global Health 5050 data tracker https://globalhealth5050.org/covid19 accessed May 8 , 2020
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COVID-19: Cases and mortality in women, 36 countries
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Global Health 5050 data tracker https://globalhealth5050.org/covid19 accessed May 8 , 2020
COVID 19: Sex disaggregated cases 
and deaths  May and August 2020
Date No 
countries
Total % Women  
(range)
% Men 
(range)
Male to 
Female 
ratio
Cases 5/8/2020 36 1,140,803 50.3 %      
(22-63)
49.7% --------
Deaths 5/8/2020 36 83,388 ----- ------ 1.62  
(0.9-3.2)
Cases 8/7/2020 72 8,163,457 46.6%  
(15-53)
53.4%  
(39-85)
-------
Deaths 8/7/2020 72 394,288 ----- ------ 1.43         
( 0.5-2.5)
Global Health 5050 data tracker https://globalhealth5050.org/covid19 accessed August 12, 2020
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USA deaths (per 100,000)  by age and sex
Data July 29, 2020
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Global Health 5050 data tracker https://globalhealth5050.org/covid19 accessed August 12, 2020
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Discussion
• Sex difference in mortality, 
with higher deaths in men
• Possible explanations
• Sex (biologically based) 
differences in the immune 
system
• Gender differences in 
environmental exposures, 
access to health care, 
desire to seek health care
• Sex/gender differences in 
co-morbid conditions
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Conclusions
• Higher mortality rates in men with COVID-19, despite 
equivalent infection rates by sex are suggested by 
preliminary country data
• The mechanisms of this difference in mortality may be 
related to sex (biological differences), comorbidities or 
gender related factors
• These data highlight the importance of disaggregating data 
by sex and gender 
• To understand disease susceptibility, prevalence and 
outcomes
• To develop safe and effective  treatments and preventive 
measures (vaccines) in men and women
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